The core activity of Proteomedix is the development and marketing of blood tests for the diagnosis of prostate cancer, in particular the product Proclarix, a non-invasive blood test that enables the identification of high-grade prostate cancer and serves as a complement to the PSA test.
AI-generated
Offering
Products & services
Industry:Medical Technology Industry
✓ Offered
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.
Next generation blood test for prostate cancer; non-invasive reflex test for elevated PSA, provides a Proclarix Risk Score and supports biopsy decision-making.
Comparisons
Proteomedix AG in comparison
Soon
Industry comparisons are coming soon
We're preparing industry comparisons that rank Proteomedix AG by reviews, experience and specialisations.
Knowledge
No knowledge articles yet
Once Proteomedix AG has claimed this profile, we'll publish editorial articles and case studies here together.